Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Genomic Imprinting in Cancer Diagnosis

NCT03882684 is registered in ClinicalTrials.gov with Chinese Alliance Against Lung Cancer as lead sponsor.

NCT NCT03882684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03882684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Genomic Imprinting in Cancer Diagnosis
Lead sponsor
Chinese Alliance Against Lung Cancer
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2017
Completion date
June 30, 2020
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, cancer, early diagnosis, genomic imprinting